| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Class A Ordinary Shares, par value $0.0001 per share |
| (b) | Name of Issuer:
Alpex Acquisition Corp |
| (c) | Address of Issuer's Principal Executive Offices:
300 Delaware Ave Suite 210 #494, Wilmington,
DELAWARE
, 19801. |
| Item 2. | Identity and Background |
|
| (a) | This statement is filed by the Sponsor and Ms. Ningdi Shi (collectively, the "Reporting Persons"). The Reporting Persons are the holders of record of approximately 18.0% of the Issuer's outstanding Ordinary Shares based on the number of ordinary shares outstanding as of June 26, 2026. |
| (b) | The principal business address of the Reporting Persons is Intershore Chambers, Road Town Tortola, British Virgin Islands. |
| (c) | Ms. Ningdi Shi is the sole member and a director of the Sponsor, which entitles her to voting, dispositive or investment power over the Sponsor. As such, Ms. Ningdi Shi is deemed to have voting and dispositive rights over the securities of the Issuer held by the Sponsor. |
| (d) | During the past five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, the persons identified in this Item 2, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
| (e) | During the past five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, the persons identified in this Item 2, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was the subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal and state securities laws of findings any violation with respect to such laws. |
| (f) | The Sponsor is a British Virgin Islands company. Ms. Ningdi Shi is citizen of the People's Republic of China. |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | The information set forth in Items 4 and 5 of this Schedule 13D are hereby incorporated by reference into this Item 3. |
| Item 4. | Purpose of Transaction |
| | On March 18, 2026, the Issuer issued 2,875,000 Class B ordinary shares, par value $0.0001 per share, to the Sponsor for a purchase price of $25,000, or approximately $0.01 per share. On March 26, 2026, the Sponsor transferred 175,000 Class B ordinary shares and 165,000 Class B ordinary shares at $0.01 per share to Xiaolin Zheng and Ying Xu, respectively. In addition, the Sponsor transferred 20,000 Class B ordinary shares at $0.01 per share to each of "Joy" Yi Hua, Xin Yue Jasmine Geffner and Yuanmei Ma, for an aggregate of 60,000 insider shares, on June 24, 2026. On June 26, 2026, simultaneously with the Issuer's initial public offering, the Sponsor acquired 187,500 private placement units in the private placement. Each private placement unit consists of one Class A ordinary share of the Issuer, one warrant exercisable for one Class A ordinary share at an exercise price of $11.50, and one right to receive one-fourth (1/4) of one Class A ordinary share of the Issuer.
Depending on prevailing market, economic and other conditions, the Reporting Persons may from time to time acquire additional Ordinary Shares or engage in discussions with the Issuer concerning future acquisitions of its shares. Such acquisitions may be made by means of open-market purchases, privately negotiated transactions, direct acquisitions from the Issuer or otherwise. Except as set forth in this Item 4, the Reporting Persons have no plans or proposals that relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board of directors of the Issuer (the "Board") or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the Board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company; (g) changes in the Issuer's charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (j) any action similar to any of those enumerated above. The Reporting Persons may, at any time and from time to time, formulate other purposes, plans or proposals regarding the Issuer, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in clauses (a) through (j) of Item 4 of Schedule 13D. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | The responses to Items 7 - 13 of the cover pages of this Schedule 13D are incorporated herein by reference. The aggregate number and percentage of ordinary shares beneficially or directly owned by the Reporting Persons is based upon a total of 14,792,500 ordinary shares outstanding as of June 26, 2026, including 11,917,500 Class A ordinary shares and 2,875,000 Class B ordinary shares. The Reporting Persons beneficially own 2,662,500 ordinary shares, representing approximately 18.0% issued and outstanding ordinary shares. |
| (b) | The responses to Items 7 - 13 of the cover pages of this Schedule 13D are incorporated herein by reference. The beneficial ownership of the Reporting Persons is 2,662,500 ordinary shares, representing approximately 18.0% issued and outstanding ordinary shares. |
| (c) | Other than the disposition of the shares as reported in this Schedule 13D, no actions in the ordinary shares were effected during the past sixty (60) days by the Reporting Persons. |
| (d) | N/A |
| (e) | N/A |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| | The information set forth in Items 4 of this Schedule 13D are hereby incorporated by reference into this Item 6. |
| Item 7. | Material to be Filed as Exhibits. |
| | 7.1 Joint Filing Agreement, dated July 2, 2026.
10.1 Securities Purchase Agreement between the Issuer and the sponsor, dated as of March 18, 2026.
https://www.sec.gov/Archives/edgar/data/2125551/000121390026042478/ea028516601ex10-7.htm
10.2 Securities Transfer agreement between the Sponsor and the CEO, dated as of March 26, 2026.
https://www.sec.gov/Archives/edgar/data/2125551/000121390026042478/ea028516601ex10-8.htm
10.3 Securities Transfer agreement between the Sponsor and the CFO, dated as of March 26, 2026.
https://www.sec.gov/Archives/edgar/data/2125551/000121390026042478/ea028516601ex10-9.htm
10.4 Securities Transfer Agreement dated June 24, 2026, among the Sponsor and certain directors of the Company.
https://www.sec.gov/Archives/edgar/data/2125551/000121390026073110/ea029617501ex10-1.htm
10.5 Private Unit Subscription Agreement, dated June 24, 2026, between the Company and the Sponsor.
https://www.sec.gov/Archives/edgar/data/2125551/000121390026073110/ea029617501ex10-2.htm |